This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure, Transparency and Plain Language Summaries
19 - 20 March, 2024
Hilton Philadelphia at Penn's Landing, PhiladelphiaHybrid Event I Attend Live In-Person or Online

Axelle De Bruyne
Clinical Trials Transparency and Disclosure Lead at Argenx


Axelle De Bruyne is the clinical trial transparency and disclosure lead at argenx. She was introduced to protocol registration and result posting 5 years ago as a regulatory liaison. To keep up with the increased and fast changing global transparency requirements, she established a clinical trials transparency and disclosure team within the organization last year. She is currently leading the disclosure activities such as protocol registration, result posting as well as the redaction and anonymization of submission documents while establishing new transparency procedures.

Agenda Sessions

  • CASE STUDY Navigating a First-Time Health Canada PRCI Submission: Learnings and Perspectives from Argenx and Privacy Analytics

  • PANEL Outsource vs. Develop Internally: How are Sponsors Meeting Mounting Disclosure Requirements?